Phase I clinical trial of SYL040012, a small interfering RNA targeting β-adrenergic receptor 2, for lowering intraocular pressure.

Phase I clinical trial of SYL040012, a small interfering RNA targeting β-adrenergic receptor 2, for lowering intraocular pressure.

Item
http://www.wikidata.org/entity/Q37690494
Drug discovery in ophthalmology: past success, present challenges, and future opportunitiesTechnologies for controlled, local delivery of siRNANew paradigms on siRNA local application.Short-interference RNAs: becoming medicines.Topical treatment of glaucoma: established and emerging pharmacology.Investigational and experimental drugs for intraocular pressure reduction in ocular hypertension and glaucoma.Genetic pharmacology: progresses in siRNA delivery and therapeutic applications.Huntington's Disease-Update on Treatments.The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market.Combination of RNA Interference and Stem Cells for Treatment of Central Nervous System Diseases.Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis.Open-angle glaucoma: therapeutically targeting the extracellular matrix of the conventional outflow pathway.The Progress of Gene Therapy for Leber`s Optic Hereditary Neuropathy.New pharmacotherapy for the treatment of glaucoma.Beta2 adrenergic receptor silencing change intraocular pressure in New Zealand rabbits.Novel therapeutics in glaucoma management.
P2860

Phase I clinical trial of SYL040012, a small interfering RNA targeting β-adrenergic receptor 2, for lowering intraocular pressure.

Item
http://www.wikidata.org/entity/Q37690494
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phase I clinical trial of SYL0 ...... lowering intraocular pressure.
@en
Phase I clinical trial of SYL0 ...... lowering intraocular pressure.
@nl
type
label
Phase I clinical trial of SYL0 ...... lowering intraocular pressure.
@en
Phase I clinical trial of SYL0 ...... lowering intraocular pressure.
@nl
prefLabel
Phase I clinical trial of SYL0 ...... lowering intraocular pressure.
@en
Phase I clinical trial of SYL0 ...... lowering intraocular pressure.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Phase I clinical trial of SYL0 ...... lowering intraocular pressure.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932